NIT
NumerixS Investment Technologies Portfolio holdings
AUM
$358M
1-Year Return
3.62%
This Quarter Return
+4.61%
1 Year Return
+3.62%
3 Year Return
+24.42%
5 Year Return
+34.25%
10 Year Return
–
AUM
$532M
AUM Growth
+$93.5M
(+21%)
Cap. Flow
+$77.9M
Cap. Flow
% of AUM
14.64%
Top 10 Holdings %
Top 10 Hldgs %
10.01%
Holding
1,485
New
401
Increased
400
Reduced
356
Closed
321
Top Buys
| 1 |
Amazon
AMZN
|
+$8.06M |
| 2 |
Qualcomm
QCOM
|
+$4.88M |
| 3 |
Home Depot
HD
|
+$4.57M |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$4.29M |
| 5 |
Carnival Corp
CCL
|
+$4.25M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$4.69M |
| 2 |
Nike
NKE
|
+$4.33M |
| 3 |
Micron Technology
MU
|
+$3.98M |
| 4 |
Baidu
BIDU
|
+$3.62M |
| 5 |
AbbVie
ABBV
|
+$3.49M |
Sector Composition
| 1 | Consumer Discretionary | 17.28% |
| 2 | Industrials | 13.61% |
| 3 | Technology | 13.58% |
| 4 | Healthcare | 11% |
| 5 | Financials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRS
626
DELISTED
Bristow Group, Inc.
BRS
| $177K | 0.03% |
+14,600
| New | +$177K |
|
627
Credit Acceptance
CACC
$5.76B
| $176K | 0.03% |
400
-900
| -69% | -$396K |
|
628
Green Dot
GDOT
$763M
| $176K | 0.03% |
2,010
-1,500
| -43% | -$131K |
|
629
Fulton Financial
FULT
$3.51B
| $176K | 0.03% |
10,500
-300
| -3% | -$5.03K |
|
630
Editas Medicine
EDIT
$237M
| $175K | 0.03% |
5,400
+399
| +8% | +$12.9K |
|
631
nLIGHT
LASR
$1.44B
| $175K | 0.03% |
+7,300
| New | +$175K |
|
632
Esperion Therapeutics
ESPR
$506M
| $175K | 0.03% |
+3,900
| New | +$175K |
|
633
BJ's Restaurants
BJRI
$698M
| $172K | 0.03% |
+2,400
| New | +$172K |
|
634
Group 1 Automotive
GPI
$6.1B
| $171K | 0.03% |
2,600
+2,500
| +2,500% | +$164K |
|
635
LCI Industries
LCII
$2.46B
| $171K | 0.03% |
2,000
-200
| -9% | -$17.1K |
|
636
SolarEdge
SEDG
$1.74B
| $171K | 0.03% |
+4,500
| New | +$171K |
|
637
Brookdale Senior Living
BKD
$1.82B
| $170K | 0.03% |
+17,887
| New | +$170K |
|
|
MFA
638
MFA Financial
MFA
$1.05B
| $170K | 0.03% |
5,679
-2,700
| -32% | -$80.8K |
|
639
Progress Software
PRGS
$1.83B
| $169K | 0.03% |
3,983
-6,817
| -63% | -$289K |
|
640
argenx
ARGX
$46.9B
| $168K | 0.03% |
+2,200
| New | +$168K |
|
641
New York Times
NYT
$9.34B
| $168K | 0.03% |
+7,300
| New | +$168K |
|
642
Parker-Hannifin
PH
$96.9B
| $168K | 0.03% |
900
-5,200
| -85% | -$971K |
|
643
Vericel Corp
VCEL
$1.54B
| $168K | 0.03% |
12,000
-2,900
| -19% | -$40.6K |
|
|
QVCGA
644
QVC Group, Inc. Series A Common Stock
QVCGA
$78.8M
| $168K | 0.03% |
157
+71
| +83% | +$76K |
|
|
TELL
645
DELISTED
Tellurian Inc.
TELL
| $168K | 0.03% |
19,400
+10,100
| +109% | +$87.5K |
|
646
Corcept Therapeutics
CORT
$7.57B
| $166K | 0.03% |
+12,100
| New | +$166K |
|
|
CSII
647
DELISTED
Cardiovascular Systems, Inc.
CSII
| $165K | 0.03% |
+4,200
| New | +$165K |
|
|
ADMS
648
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $165K | 0.03% |
8,600
-200
| -2% | -$3.84K |
|
649
Comerica
CMA
$8.88B
| $164K | 0.03% |
1,800
-600
| -25% | -$54.7K |
|
650
Globe Life
GL
$11.3B
| $164K | 0.03% |
1,900
-800
| -30% | -$69.1K |
|